Companies: 10,795·Total market cap: $144.5T
Altimmune, Inc.

Altimmune, Inc.

ALTNASDAQHealthcare● Active
$2.73
+$0.02(+0.55%)
Market Cap$240501143
P/E Ratio
52W High$7.73
52W Low$2.56

Altimmune, Inc.(ALT)· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · ALT · 截至 2026-06-08

财务报表

Revenue · Gross Profit · Net Income
Breakdown2025-122024-122023-122022-122021-12
Revenue
Revenue$0.04M$0.02M$0.43M($0.07M)$4.41M
Cost of Revenue$0.00M$0.00M$0.00M$0.00M$0.00M
Gross Profit$0.04M$0.02M$0.43M($0.07M)$4.41M
Gross Margin %(computed)100.00%100.00%100.00%100.00%100.00%
Operating Expenses
R&D Expenses$66.43M$82.23M$65.80M$70.54M$74.54M
G&A Expenses$28.10M$20.97M$18.14M$17.13M$15.41M
Total Operating Expenses$94.53M$103.19M$96.36M$87.67M$101.32M
Operating Income($94.49M)($103.17M)($95.93M)($87.74M)($96.91M)
Operating Margin %(computed)
Interest Income$7.54M$8.07M$7.35M$2.87M$0.20M
Interest Expense$1.64M$0.01M$0.04M$0.01M$0.01M
Income Before Tax($88.77M)($95.06M)($88.45M)($84.91M)($97.09M)
Income Tax Expense($0.68M)$0.00M$0.00M($0.20M)$0.00M
Net Income($88.09M)($95.06M)($88.45M)($84.71M)($97.09M)
Net Margin %(computed)
Per Share & EBITDA
EPS (Basic)$-1.00$-1.34$-1.66$-1.81$-2.35
Wtd Avg Shares88.10M71.00M53.25M46.93M41.28M
EBITDA($87.03M)($94.81M)($87.94M)($84.41M)($96.53M)
EBITDA Margin %(computed)

数据来源:Financial Modeling Prep · 最后更新:2026-06-08 · USD · M

深入了解Altimmune, Inc.

关于Altimmune, Inc.(ALT)损益表

Altimmune, Inc.(ALT)损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年,ALT实现营收$0.00B,毛利润$0.00B(毛利率100.00%),净利润($0.09B)(净利率-214860.98%)。

常见问题

ALT · 4 问

Altimmune, Inc.(ALT)2025财年营收为$0.00B,同比up105.0%。

ALT revenueALT salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08